Welcome to our dedicated page for PACS Group SEC filings (Ticker: PACS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The PACS Group, Inc. (NYSE: PACS) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a healthcare holding company in the post-acute care and medical care facilities space, PACS uses SEC reports to describe its facility portfolio, credit arrangements, governance, and risk profile.
Investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of PACS Group’s operations, financial condition, and risk factors. These filings also provide context on the company’s role as a holding company, the structure of its independent operating subsidiaries, and the separation between licensed healthcare providers and non-provider entities. AI-generated highlights can point out key sections on post-acute care operations, use of credit facilities, and lease obligations.
Current reports on Form 8-K are particularly important for PACS, given its history of restatements, credit agreement amendments, and NYSE listing updates. Recent 8-K filings have addressed topics such as forbearance and amendments under the company’s amended and restated credit agreement, events of default and related waivers, NYSE listing extensions tied to delayed SEC filings, and the completion of an independent Audit Committee investigation and related restatements. AI summaries can help users quickly understand the implications of these events.
Users can also access proxy materials such as the Definitive Proxy Statement on Schedule 14A, which outlines matters presented to stockholders at the annual meeting, including director elections, auditor ratification, and advisory votes on executive compensation. In addition, the filings page provides real-time updates from EDGAR and convenient access to other forms, such as notifications of late filings on Form 12b-25. Together, these documents offer a comprehensive view of PACS Group’s regulatory history, governance decisions, and financial reporting, with AI tools available to simplify and explain complex disclosures.
PACS Group, Inc. reported that Chief Financial Officer Derick Apt resigned on September 2, 2025 after the board’s Audit Committee, following allegations he accepted a series of high-value items from individuals linked to entities that do business with the company, made interim findings that his receipt of those items violated company policies and its Code of Conduct. In a separation agreement, Apt provided a broad release of claims and reaffirmed non-solicitation, non-disparagement and confidentiality covenants, while the company agreed to accelerate vesting of 82,116 restricted stock units, with his remaining unvested units forfeited, and waived a one-year non-competition covenant. The company has launched a search for a permanent CFO and bolstered its finance and accounting resources. On September 3, 2025, co-founder and current Executive Vice Chairman Mark Hancock, who previously served as CFO from 2013 to 2024, was appointed interim Chief Financial Officer and will act as principal financial officer while continuing as a director.
PACS Group, Inc. disclosed that Peter (P.J.) Sanford, President of Providence Administrative Consulting Services, Inc., resigned as an employee and executive officer of the company effective August 15, 2025. The parties negotiated a separation agreement under which Mr. Sanford will execute a general release of claims and reaffirm his continuing obligations under certain restrictive covenants. The company agreed to subsidize 12 months of Mr. Sanford's COBRA premiums. The company will also enter a consulting agreement to keep Mr. Sanford available to provide services. The filing states the full separation and consulting agreements will be filed as exhibits to the company's next quarterly report.
PACS Group, Inc. filed a Form 12b-25 notifying the SEC of a late Form 10-Q for the quarter ended June 30, 2024. The company states the delay is due to an ongoing investigation and that management is working to complete that review before filing. The notice contains standard forward-looking language that outcomes and timing may change and refers investors to the company’s disclosed Risk Factors.